Abstract
We recently identified an erythrocyte nucleotide accumulating in end-stage renal disease as 4-pyridone-3-carboxamide ribonucleotide triphosphate (4PYTP), a nucleotide never described previously. Plasma tryptophan concentration has been previously reported to be reduced in patients in chronic renal failure that is in turn associated with elevated precursors of tryptophan metabolism, including l-kynurenine and quinolinic acid, both of which have been implicated in the neurotoxic manifestations of chronic renal failure. Here we compare mean erythrocyte 4PYTP, and plasma tryptophan concentrations, in controls and four patient groups with renal impairment (10 per group) and confirmed a reduction in plasma tryptophan in patients on dialysis that corrected with renal transplantation. We found: An inverse correlation between plasma tryptophan and red cell 4PYTP concentrations (R2=0.44, P<0.001) when all patients were grouped together. Restoration of both tryptophan and 4PYTP concentrations to control values was only achieved following renal transplantation. 4PYTP was absent from erythrocytes in Molybdenum cofactor (MoCF) deficiency implicating aldehyde oxidase/dehydrogenase, a Molybdenum requiring enzyme. High 4PYTP erythrocyte concentrations in adenine or hypoxanthine-phosphoribosyltransferase deficient patients in severe uremia (113 μM and 103 μM), confirmed the lack of involvement of either enzyme in 4PYTP formation. We propose that 4PYTP is formed by a novel route involving the oxidation of the intermediates of NAD turnover from quinolinic acid by aldehyde oxidase.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Horl WH (1998) Genesis of the uraemic syndrome: role of uraemic toxins. Wien Klin Wochenschr 110[15]:511–20. Ref Type: Generic
Asatoor AM (1968) Retention of pseudouridine and 4-amino-5-imidazole carboxamide in uraemia. Clin Chim Acta 20:407–411
Slominska EM, Smolenski RT, Szolkiewicz M, Leaver N, Rutkowski B, Simmonds HA, Swierczynski J (2002) Accumulation of plasma N-methyl-2-pyridone-5-carboxamide in patients with chronic renal failure. Mol Cell Biochem 231:83–88
Carrey EA, Smolenski RT, Edbury SM, Laurence A, Marinaki AM, Duley JA, Zhu L, Goldsmith DJ, Simmonds HA (2003) Origin and characteristics of an unusual pyridine nucleotide accumulating in erythrocytes: positive correlation with degree of renal failure. Clin Chim Acta 335:117–129
Rejman AS, Mansell MA, Grimes AJ, Joekes AM (1985) Rapid correction of red-cell nucleotide abnormalities following successful renal transplantation. Br J Haematol 61:433–443
Marlewski M, Smolenski RT, Swierczynski J, Rutkowski B, Duley JA, Simmonds HA, Zydowo MM (1994) Accelerated purine base salvage-a possible cause of elevated nucleotide pool in the erythrocytes of patients with uraemia. Adv Exp Med Biol 370:19–22
Slominska EM, Carrey EA, Foks H, Orlewska C, Wieczerzak E, Sowinski P, Yacoub MH, Marinaki AM, Simmonds HA, Smolenski RT (2006) A novel nucleotide found in human erythrocytes, 4-pyridone-3-carboxamide-1-beta-D-ribonucleoside triphosphate. J Biol Chem 281:32057–32064
Simmonds HA, Panayi GS, Corrigall V (1978) A role for purine metabolism in the immune response: Adenosine-deaminase activity and deoxyadenosine catabolism. Lancet 1:60–63
Hughes EF, Fairbanks L, Simmonds HA, Robinson RO (1998) Molybdenum cofactor deficiency-phenotypic variability in a family with a late-onset variant. Dev Med Child Neurol 40:57–61
Simmonds HA, Duley JA, Davies PM (1991) Analysis of purines and pyrimidines in blood, urine and other physiological fluids. Techniques in Diagnostic Human Biochemical Genetics: A laboratory Manual, pp 397–424. Ref Type: Generic
Ruckemann K, Fairbanks LD, Carrey EA, Hawrylowicz CM, Richards DF, Kirschbaum B, Simmonds HA (1998) Leflunomide inhibits pyrimidine de novo synthesis in mitogen-stimulated T-lymphocytes from healthy humans. J Biol Chem 273:21682–21691
Cernacek P, Becvarova H, Gerova Z, Valek A, Spustova V (1980) Plasma tryptophan level in chronic renal failure. Clin Nephrol 14:246–249
Saito K, Fujigaki S, Heyes MP, Shibata K, Takemura M, Fujii H, Wada H, Noma A, Seishima M (2000) Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency. Am J Physiol Renal Physiol 279:F565–F572
Carrey EA, Smolenski RT, Edbury SM, Laurence A, Marinaki AM, Duley JA, Zhu LM, Goldsmith DJ, Simmonds HA (2004) An unusual pyridine nucleotide accumulating in erythrocytes: its identity and positive correlation with degree of renal failure. Nucleosides Nucleotides Nucleic Acids 23:1135–1139
Magni G, Amici A, Emanuelli M, Orsomando G, Raffaelli N, Ruggieri S (2004) Enzymology of NAD+ homeostasis in man. Cell Mol Life Sci 61:19–34
Guillemin GJ, Meininger V, Brew BJ (2005) Implications for the kynurenine pathway and quinolinic acid in amyotrophic lateral sclerosis. Neurodegener Dis 2:166–176
Pawlak D, Koda M, Pawlak S, Wolczynski S, Buczko W (2003) Contribution of quinolinic acid in the development of anemia in renal insufficiency. Am J Physiol Renal Physiol 284:F693–F700
Smythe GA, Poljak A, Bustamante S, Braga O, Maxwell A, Grant R, Sachdev P (2003) ECNI GC-MS analysis of picolinic and quinolinic acids and their amides in human plasma, CSF, and brain tissue. Adv Exp Med Biol 527:705–712
Fukuwatari T, Morikawa Y, Hayakawa F, Sugimoto E, Shibata K (2001) Influence of adenine-induced renal failure on tryptophan-niacin metabolism in rats. Biosci Biotechnol Biochem 65:2154–2161
Duran M, de Bree PK, de Klerk JBC, Dorland L (1996) Molybdenum cofactor deficiency. Clinical presentation and laboratory diagnosis. Int Paediatr 11:334–337. Ref Type: Generic
Pai EF, Nishino T (2002) The molybdenum-containing xanthine oxidoreductases and picolinate dehydrogenases. Met Ions Biol Syst 39:431–454
Helander A (1993) Aldehyde dehydrogenase in blood: distribution, characteristics and possible use as marker of alcohol misuse. Alcohol Alcohol 28:135–145
Wierzchowski J, Wroczynski P, Laszuk K, Interewicz E (1997) Fluorimetric detection of aldehyde dehydrogenase activity in human blood, saliva, and organ biopsies and kinetic differentiation between class I and class III isozymes. Anal Biochem 245:69–78
Simmonds HA, Reiter S, Davies PM, Cameron JS (1991) Orotidine accumulation in human erythrocytes during allopurinol therapy:association with high urinary oxipurinol-1-riboside concentrations in patients with renal failure and the Lesch-Nyhan syndrome. Clin Sci 80:191–197
Kalikin L, Calvo KC (1988) Inhibition of quinolinate phosphoribosyl transferase by pyridine analogs of quinolinic acid. Biochem Biophys Res Commun 152:559–564
Mikogami T, Marianne T, Spik G (1995) Effect of intracellular iron depletion by picolinic acid on expression of the lactoferrin receptor in the human colon carcinoma cell subclone HT29-18-C1. Biochem J 308(Pt 2):391–397
Topczewska-Bruns J, Pawlak D, Tankiewicz A, Chabielska E, Buczko W (2003) Kynurenine metabolism in central nervous system in experimental chronic renal failure. Adv Exp Med Biol 527:177–182
Niwa T, Yoshizumi H, Emoto Y, Miyazaki T, Hashimoto N, Takeda N, Tatematsu A, Maeda K (1991) Accumulation of quinolinic acid in uremic serum and its removal by hemodialysis. Clin Chem 37:159–161
Foster AC, Schwarcz R (1985) Characterization of quinolinic acid phosphoribosyltransferase in human blood and observations in Huntington’s disease. J Neurochem 45:199–205
Ruckemann K, Laurence A, Fairbanks LD, Richards D, Smolenski RT, Hawrylowicz C, Bofill M, Simmonds HA (1998) Biochemical basis for the impaired immune response in chronic renal failure? Adv Exp Med Biol 431:559–563
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Laurence, A., Edbury, S.M., Marinaki, A.M. et al. 4-pyridone-3-carboxamide ribonucleoside triphosphate accumulating in erythrocytes in end stage renal failure originates from tryptophan metabolism. Clin. Exper.Med. 7, 135–141 (2007). https://doi.org/10.1007/s10238-007-0137-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10238-007-0137-8